HS Icon Blood, antisera, vaccines, toxins and cultures in  Flag Belgium

2019
Exports | Imports
: $20.3B | $16.5B, World Rnk 5 / 201
Flag Rnk 4 / 1215 | World Rnk 3 / 222
Flag Rnk 4 / 1214

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $2.86B | $650M, United States |  France

2019
ECONOMIC COMPLEXITY of Belgium
: 1.32, Rnk 18 / 147

2019
PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures
: 1.19, Rnk 110 / 1029

Exports In 2019, Belgium exported $20.3B in Blood, antisera, vaccines, toxins and cultures, making it the 5th largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 4th most exported product in Belgium. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Belgium are: United States ($5.78B), Germany ($2.3B), France ($1.46B), Italy ($1.42B), and United Kingdom ($1.17B).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Belgium between 2018 and 2019 were United States ($2.86B), Italy ($483M), and Germany ($324M).

Imports In 2019, Belgium imported $16.5B in Blood, antisera, vaccines, toxins and cultures, becoming the 3rd largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 4th most imported product in Belgium. Belgium imports Blood, antisera, vaccines, toxins and cultures primarily from: Ireland ($7.5B), France ($2.16B), United States ($1.88B), Switzerland ($1.58B), and Germany ($1.12B).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Belgium between 2018 and 2019 were France ($650M), Austria ($266M), and Switzerland ($221M).

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2019): $20.3B

IMPORTS (2019): $16.5B

NET TRADE (2019): $3.79B

In 2019, Belgium exported $20.3B in Blood, antisera, vaccines, toxins and cultures. The main destinations of Belgium exports on Blood, antisera, vaccines, toxins and cultures were United States ($5.78B), Germany ($2.3B), France ($1.46B), Italy ($1.42B), and United Kingdom ($1.17B).

In 2019, Belgium imported $16.5B in Blood, antisera, vaccines, toxins and cultures, mainly from Ireland ($7.5B), France ($2.16B), United States ($1.88B), Switzerland ($1.58B), and Germany ($1.12B).

Explore Visualizations

IN 2019, Belgium HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2019, Belgium HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Belgium WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Belgium WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2019, Belgium's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2019, Belgium's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2017, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Belgium were of 0% around the world.